Biotin interference in immunoassays mimicking subclinical Graves’ disease and hyperestrogenism: a case series
- 1 June 2017
- journal article
- research article
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 55 (6) , e99-e103
Abstract
Article Biotin interference in immunoassays mimicking subclinical Graves’ disease and hyperestrogenism: a case series was published on June 1, 2017 in the journal Clinical Chemistry and Laboratory Medicine (CCLM) (volume 55, issue 6).Keywords
This publication has 8 references indexed in Scilit:
- Factitious Graves' Disease Due to Biotin Immunoassay Interference—A Case and Review of the LiteratureThe Journal of Clinical Endocrinology & Metabolism, 2016
- Biotin Treatment Mimicking Graves’ DiseaseNew England Journal of Medicine, 2016
- Misdiagnosis of Graves' Disease with Apparent Severe Hyperthyroidism in a Patient Taking Biotin MegadosesThyroid®, 2016
- Falsely Low Parathyroid Hormone Secondary to Biotin Interference: A Case SeriesEndocrine Practice, 2013
- Biotin interference on TSH and free thyroid hormone measurementPathology, 2012
- A Case of Renal Osteodystrophy with Unexpected Serum Intact Parathyroid Hormone ConcentrationsClinical Chemistry, 2009
- Biotin biochemistry and human requirementsThe Journal of Nutritional Biochemistry, 1999
- The biotin-(strept)avidin system: principles and applications in biotechnologyClinical Chemistry, 1991